XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Hill Share of Stockholders' Equity
Common Stock
Additional Paid-in Capital
Retained Earnings (Deficit)
Accumulated Other Comprehensive (Loss)
Treasury Stock
Non-controlling Interests
Balance at beginning of period (in shares) at Dec. 31, 2018     62,181       6,546  
Balance at beginning of period at Dec. 31, 2018 $ 94,445 $ 93,840 $ 6 $ 210,084 $ (85,444) $ (2,575) $ (28,231) $ 605
Increase (decrease) in stockholders' equity                
Net (loss) income (368) (518)     (518)     150
Other comprehensive income (loss) (874) (938)       (938)   64
Stock issued to Board of Directors (in shares)     24          
Stock issued to Board of Directors 0              
Share-based compensation expense 1,042 1,042   1,042        
Stock issued under employee stock purchase plan (in shares)     57          
Stock issued under employee stock purchase plan 113 113   113        
Balance at end of period (in shares) at Jun. 30, 2019     62,262       6,546  
Balance at end of period at Jun. 30, 2019 94,358 93,539 $ 6 211,239 (85,962) (3,513) $ (28,231) 819
Balance at beginning of period (in shares) at Dec. 31, 2018     62,181       6,546  
Balance at beginning of period at Dec. 31, 2018 94,445 93,840 $ 6 210,084 (85,444) (2,575) $ (28,231) 605
Increase (decrease) in stockholders' equity                
Net (loss) income 2,139              
Balance at end of period (in shares) at Sep. 30, 2019     62,705       6,546  
Balance at end of period at Sep. 30, 2019 97,882 97,031 $ 6 212,493 (83,481) (3,756) $ (28,231) 851
Balance at beginning of period (in shares) at Jun. 30, 2019     62,262       6,546  
Balance at beginning of period at Jun. 30, 2019 94,358 93,539 $ 6 211,239 (85,962) (3,513) $ (28,231) 819
Increase (decrease) in stockholders' equity                
Net (loss) income 2,507 2,481     2,481     26
Other comprehensive income (loss) (237) (243)       (243)   6
Stock issued to Board of Directors (in shares)     104          
Stock issued to Board of Directors $ 0              
Share-based compensation expense (in shares) 322              
Share-based compensation expense $ 1,212 1,212   1,212        
Stock issued under employee stock purchase plan (in shares) [1]     17          
Stock issued under employee stock purchase plan [1] 42 42   42        
Balance at end of period (in shares) at Sep. 30, 2019     62,705       6,546  
Balance at end of period at Sep. 30, 2019 $ 97,882 97,031 $ 6 212,493 (83,481) (3,756) $ (28,231) 851
Balance at beginning of period (in shares) at Dec. 31, 2019 62,708   62,708       6,546  
Balance at beginning of period at Dec. 31, 2019 $ 110,228 109,357 $ 6 212,759 (71,360) (3,817) $ (28,231) 871
Increase (decrease) in stockholders' equity                
Net (loss) income (8,358) (8,535)     (8,535)     177
Other comprehensive income (loss) 4,746 5,096       5,096   (350)
Share-based compensation expense 1,201 1,201   1,201        
Stock issued under employee stock purchase plan (in shares)     162          
Stock issued under employee stock purchase plan 201 201   201        
Transfer of shares pledged as collateral (in shares) [2]     261       261  
Transfer of shares pledged as collateral [2] (825) (825)         $ (825)  
Balance at end of period (in shares) at Jun. 30, 2020     62,609       6,807  
Balance at end of period at Jun. 30, 2020 $ 107,193 106,495 $ 6 214,161 (79,895) 1,279 $ (29,056) 698
Balance at beginning of period (in shares) at Dec. 31, 2019 62,708   62,708       6,546  
Balance at beginning of period at Dec. 31, 2019 $ 110,228 109,357 $ 6 212,759 (71,360) (3,817) $ (28,231) 871
Increase (decrease) in stockholders' equity                
Net (loss) income $ (6,113)              
Balance at end of period (in shares) at Sep. 30, 2020 62,916   62,916       6,807  
Balance at end of period at Sep. 30, 2020 $ 110,512 109,438 $ 6 214,596 (77,781) 1,673 $ (29,056) 1,074
Balance at beginning of period (in shares) at Jun. 30, 2020     62,609       6,807  
Balance at beginning of period at Jun. 30, 2020 107,193 106,495 $ 6 214,161 (79,895) 1,279 $ (29,056) 698
Increase (decrease) in stockholders' equity                
Net (loss) income 2,245 2,114     2,114     131
Other comprehensive income (loss) 639 394       394   245
Stock issued to Board of Directors (in shares)     291          
Stock issued to Board of Directors 0              
Share-based compensation expense 415 415   415        
Stock issued under employee stock purchase plan (in shares)     16          
Stock issued under employee stock purchase plan $ 20 20   20        
Balance at end of period (in shares) at Sep. 30, 2020 62,916   62,916       6,807  
Balance at end of period at Sep. 30, 2020 $ 110,512 $ 109,438 $ 6 $ 214,596 $ (77,781) $ 1,673 $ (29,056) $ 1,074
[1] Included $21 of proceeds related to ESPP shares issued during the three months ended September 30, 2019 that were received in the subsequent period, but were excluded in Hill International, Inc.'s (the "Company") consolidated statements of cash flows.
[2] Reflects 261 shares of the Company's common stock pledged as collateral under the terms of a secured promissory note payable to the Company. During the three months ended March 31, 2020, the Company exercised its right to retain the shares upon the note holder's agreement to relinquish the shares upon the promissory note maturity date.